Publication:
Gut hormones and gut microbiota: implications for kidney function and hypertension

dc.contributor.coauthorAfşar, Barış
dc.contributor.coauthorVaziri, Nosratola D.
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorAslan, Gamze
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.kuauthorTarım, Kayhan
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T22:52:50Z
dc.date.issued2016
dc.description.abstractIncreased blood pressure (BP) and chronic kidney disease are two leading risk factors for cardiovascular disease. Increased sodium intake is one of the most important risk factors for development of hypertension. Recent data have shown that gut influences kidney function and BP by variety of mechanisms. Various hormones and peptides secreted from gut such as gastrin, glucocorticoids, Glucagon-like peptide-1 impact on kidney function and BP especially influencing sodium absorption from gut. These findings stimulate scientist to find new therapeutic options such as tenapanor for treatment of hypertension by blocking sodium absorption from gut. The gastrointestinal tract is also occupied by a huge community of microbes (micro-biome) that under normal condition has a symbiotic relationship with the host. Alterations in the structure and function of the gut microbiota have been shown to play a key role in the pathogenesis and complications of numerous diseases including hypertension. Based on these data, in this review, we provide a summary of the available data on the role of gut and gut microbiota in regulation of BP and kidney function. (C) 2016 American Society of Hypertension. All rights reserved.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue12
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume10
dc.identifier.doi10.1016/j.jash.2016.10.007
dc.identifier.eissn1878-7436
dc.identifier.issn1933-1711
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85006132466
dc.identifier.urihttps://doi.org/10.1016/j.jash.2016.10.007
dc.identifier.urihttps://hdl.handle.net/20.500.14288/7069
dc.identifier.wos390293000008
dc.keywordsIntestinal hormones
dc.keywordsKidney disease
dc.keywordsMicrobiota
dc.keywordsNa plus /H plus exchanger-3 glucagon-like peptide-1
dc.keywordsBlood-pressure
dc.keywordsPharmacological inhibition
dc.keywordsDietary-sodium
dc.keywordsSalt intake
dc.keywordsReceptor
dc.keywordsAbsorption
dc.keywordsNHE3
dc.keywordsImprovement
dc.keywordsExpression
dc.language.isoeng
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of The American Society of Hypertension
dc.subjectPeripheral vascular disease
dc.titleGut hormones and gut microbiota: implications for kidney function and hypertension
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorAslan, Gamze
local.contributor.kuauthorTarım, Kayhan
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1KUH (KOÇ UNIVERSITY HOSPITAL)
local.publication.orgunit2KUH (Koç University Hospital)
local.publication.orgunit2School of Medicine
person.familyNameAslan
person.familyNameKanbay
person.familyNameTarım
person.givenNameGamze
person.givenNameMehmet
person.givenNameKayhan
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files